Home Medicine Global DNA methylation measured by liquid chromatography-tandem mass spectrometry: analytical technique, reference values and determinants in healthy subjects
Article
Licensed
Unlicensed Requires Authentication

Global DNA methylation measured by liquid chromatography-tandem mass spectrometry: analytical technique, reference values and determinants in healthy subjects

  • Robert M. Kok , Desirée E.C. Smith , Rob Barto , Annemieke M.W. Spijkerman , Tom Teerlink , Henk J. Gellekink , Cornelis Jakobs and Yvo M. Smulders
Published/Copyright: July 8, 2007
Clinical Chemistry and Laboratory Medicine (CCLM)
From the journal Volume 45 Issue 7

Abstract

Background: Alterations in global DNA methylation are implicated in various pathobiological processes. We describe a liquid chromatography-electrospray ionization-tandem mass spectrometry (LC-ESI-MS/MS) method for determination of cytosine and 5-methylcytosine in DNA.

Methods: DNA was hydrolyzed using formic acid. Cytosine and 5-methylcytosine were separated by gradient-elution reversed-phase chromatography with a mobile phase containing nonafluoropentanoic acid (NFPA) as ion-pairing reagent and quantified using stable isotope dilution LC-ESI-MS/MS. The method was applied to DNA isolated from leukocytes of healthy volunteers.

Results: Linear calibration curves were obtained in the range 0.111–4.422 ng/μL [mean correlation co-efficient 0.9983 (SD=0.0011), n=9] for cytosine and 0.0048–0.1936 ng/μL [mean correlation coefficient 0.9991 (SD=0.0010), n=9] for 5-methylcytosine. The intra- and inter-assay CVs for the 5-methylcytosine/total cytosine ratio (mCyt/tCyt) was 1.7% (n=9) and 3.5% (n=8) for calf thymus DNA (mean mCyt/tCyt ratio 6.5%), and 4.5% (n=6) and 6.5% (n=14), respectively for pBR322 DNA (mean mCyt/tCyt ratio 0.48%). The limit of detection (signal-to-noise ratio 3) was 2 pg on-column for cytosine and 5-methylcytosine. In healthy subjects (n=109), the mCyt/tCyt ratio varied from 2.6% to 4.8% (median 4.1%). DNA methylation was negatively correlated to age, but only in subjects with the methylenetetrahydrofolate reductase (MTHFR) 677 TT genotype (p=0.046). No association with B-vitamin status was observed.

Conclusions: This LC-ESI-MS/MS method is easy to perform and offers reproducibility, selectivity and sensitivity for studying DNA methylation. The method allows a sample throughput of approximately 200 samples/week. The MTHFR C677T genotype influences age-related changes in DNA methylation.

Clin Chem Lab Med 2007;45:903–11.


Corresponding author: Yvo M. Smulders, MD, VU University Medical Center, Department of Internal Medicine, P.O. Box 7057, Amsterdam 1007 MB, The Netherlands Phone: +31-20-4444307, Fax: +31-20-4444313

Received: 2007-1-17
Accepted: 2007-2-7
Published Online: 2007-07-08
Published in Print: 2007-07-01

©2007 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Pharmacogenomics and Personalized Medicine – a global reality check
  2. Pharmacogenomics and adverse drug reactions in diagnostic and clinical practice
  3. Impact of genetic polymorphisms on the risk of lipid disorders in patients on anti-HIV therapy
  4. Polymorphisms in genes involved in DNA repair and metabolism of xenobiotics in individual susceptibility to sporadic diffuse gastric cancer
  5. Effect of 13-cis-retinoic acid on the genetic expression profile of human umbilical vein endothelial cells (HUVECs) determined by microarray
  6. Association between T102C and A–1438G polymorphisms in the serotonin receptor 2A (5-HT2A) gene and schizophrenia: relevance for treatment with antipsychotic drugs
  7. A1166C polymorphism of the angiotensin AT1 receptor (AT1R) gene alters endothelial response to statin treatment
  8. Third Santorini conference pharmacogenomics workshop report: “Pharmacogenomics at the crossroads: what else than good science will be needed for the field to become part of Personalized Medicine?”
  9. On detecting interference from endogenous antibodies in immunoassays by doubling dilutions test
  10. High-sensitivity C-reactive protein concentration in patients with myocardial infarction-environmental factors, and polymorphisms in interleukin-10 and CD14 genes
  11. Tankyrase-1 mRNA expression in bladder cancer and paired urine sediment: preliminary experience
  12. A novel application of melting curves: utility of peak area calculation for relative methylation quantification
  13. Paraoxonase 1 gene polymorphisms in angiographically assessed coronary artery disease: evidence for gender interaction among Brazilians
  14. Tumor necrosis factor-α and oxidant status are essential participating factors in unexplained recurrent spontaneous abortions
  15. Paraoxonase and platelet-activating factor acetylhydrolase activities in lipoproteins of β-thalassemia/hemoglobin E patients
  16. Analysis of glomerular filtration rate, serum cystatin C levels, and renal resistive index values in cirrhosis patients
  17. Direct determination of selenium in human serum by inductively coupled plasma-collision cell-mass spectrometry
  18. Within-subject variation of plasma resistin levels over a 1-year period
  19. Global DNA methylation measured by liquid chromatography-tandem mass spectrometry: analytical technique, reference values and determinants in healthy subjects
  20. Values for free/total prostate-specific antigen ratio as a function of age: necessity of reference validation in a Turkish population
  21. Comparison of the Roche COBAS Amplicor™ Monitor, Roche COBAS Ampliprep™/COBAS Taqman™ and Abbott RealTime™ Test assays for quantification of hepatitis C virus and HIV RNA
  22. Genetic cystic fibrosis transmembrane regulator 4016insT D1152H compound heterozygosity and male infertility: an Italian case report
  23. Reference intervals for serum cystatin C in healthy Mexican adults
  24. Could standard ISO 15189 be useful for the conundrum of CA 19-9/GI Monitor measurement?
  25. Quality control strategy to verify day-to-day imprecision of length of blood sedimentation reaction measurements with the TEST-1 analyzer
  26. Applicability of α-fetoprotein-concanavalin A (AFP-ConA) binding to discriminate between germinal or hepatic origin of AFP in germ cell tumour patients during chemotherapy or follow-up
  27. Proposal of a candidate international conventional reference measurement procedure for free thyroxine in serum
  28. Balkan Clinical Laboratory Federation − past, present and future trends
Downloaded on 17.2.2026 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2007.137/html
Scroll to top button